Overview

• Apollo Health and Lifestyle Ltd. will be 99.42% owned by Apollo Hospitals after completion, with the balance in the ESOP pool.
• The share purchase is targeted to close by end-November 2025, pending regulatory approvals including from the Competition Commission of India and other closing formalities.
• The board cleared a two-phase, 100-bed comprehensive oncology centre in Gurugram with a total outlay of ₹573 crore as part of the hospital’s Phase 2 expansion.
• The facility will include a Proteus One proton beam therapy system and is expected to add treatment capacity for about 350 patients annually.
• Phase 1 of the Gurugram hospital is slated to commission by end-Q4 FY25 or Q1 FY26, and Apollo is targeting an oncology business of over ₹5,000 crore within 3–4 years, with shares little changed and most analysts positive.